Novo Nordisk Gets 401(k) Investment Suit Narrowed
A New Jersey federal judge dismissed allegations accusing Novo Nordisk of unlawfully keeping underperforming investment options in its employee 401(k) plan, handing the pharmaceutical company a partial win by concluding workers...To view the full article, register now.
Already a subscriber? Click here to view full article